Background and Purpose-Because atherosclerosis is a systemic disease, presence and composition on 1 location may relate to ischemic events in distant locations. We examined whether carotid atherosclerotic wall thickness, stenosis, and plaque composition are related to history of ischemic stroke and coronary heart disease (CHD). Methods-From the population-based Rotterdam Study, 1731 asymptomatic participants (mean age, 72.4±9.1 years; 55% males) underwent magnetic resonance imaging of both carotid arteries. We assessed carotid wall thickness, stenosis and plaque composition, that is presence of intraplaque hemorrhage, lipid, and calcification. History of ischemic stroke and CHD was assessed until date of magnetic resonance imaging. The study was approved by the institutional review board, and all participants gave informed consent. Logistic regression analyses adjusted for age and traditional cardiovascular risk factors were used to study sex-specific associations between plaque characteristics and clinical events. Results-We found that both carotid stenosis and intraplaque hemorrhage were associated with ischemic stroke in men but not in women 
A therosclerosis is the primary cause of cardiovascular disease, with coronary heart disease (CHD) and ischemic stroke as its most important clinical manifestations. Atherosclerosis is clinically silent for years with gradual thickening of the vessel wall and changes in plaque composition. Previous data suggest that plaque vulnerability depends on its composition, rather than on its thickness or the severity of stenosis. 1 One of the vessel beds most extensively studied in atherosclerosis is the carotid artery because it can be easily visualized using different imaging techniques. Whereas ultrasound was for long the main modality for assessing carotid wall thickness, technical advances in other imaging modalities, especially magnetic resonance imaging (MRI), now allow a better characterization of plaque composition. Plaque components that can reliably be characterized on MRI are lipid deposits with or without a necrotic core, calcification, and intraplaque hemorrhage (IPH). Among these, IPH has gained much attention because it has been recognized as an important determinant of plaque instability and subsequent risk of stroke. 2, 3 An important feature of atherosclerosis is that it is a systemic vascular disease and that the presence of atherosclerotic disease at one specific location may predict ischemic events in distant locations. [4] [5] [6] [7] [8] In this context, intima media thickness (IMT) in the carotid arteries has previously been used to assess the risk of CHD. [9] [10] [11] Also, specific properties of carotid plaques, such as irregularity of the plaque surface, were found to be associated with atherosclerotic plaque irregularity in other vessel beds. 12 Subsequently, it was postulated that systemic risk factors might lead to a systemic predisposition to irregularity and rupture of atherosclerotic plaques. Such a predisposition to plaque instability attributable to systemic risk factors would suggest that plaque composition and instability in the carotid arteries could be related not only to stroke but also to other events, such as CHD. 13 Therefore, in this study, we investigated the association of extent of carotid atherosclerosis and carotid plaque composition with a history of ischemic stroke and CHD in a population-based cohort study.
Methods

Study Population
The subjects of this study are participants of the Rotterdam Study, a prospective population-based cohort study initiated in 1990 among persons 55 years and older in the municipality of Rotterdam, the Netherlands. 14 The original cohort of the Rotterdam Study was expanded in 2000, and again in 2006 to include participants who were 45 years and older. All study participants routinely undergo carotid ultrasonography to assess carotid IMT (measured as maximum distance between the near and far wall). 15 Of 10073 participants with carotid ultrasound, 3795 participants (38%) had wall thickness ≥2.5 mm in at least one carotid, which was the inclusion criterion for participating in the current carotid MRI study. From the 3795 with wall thickening we invited 2666 participants to undergo an MRI of the carotid arteries. The remaining 1129 participants had passed away, moved out of the study area, were physically disabled (n=701), or had known MRI contraindications (n=428). From the 2666 persons, 684 did not undergo MRI scanning, because of claustrophobia (n=57), physical restrictions (n=191), contraindications (n=115), refusal to participate (n=272), no show or lost to follow-up (n=49). The remaining 1982 participants (74% of those initially invited) underwent MRI scanning of both carotid arteries. Scans were excluded if image quality was bad (n=95), if no plaque ≥2 mm were observed bilaterally (n=41) or if scanning was interrupted due to claustrophobia (n=106). Of the remaining 1739 participants with carotid MRI scans, we excluded participants with incomplete information on prevalence of CHD (n=8) or stroke (n=48). The Rotterdam Study has been approved by the medical ethics committee according to the Population Study Act Rotterdam Study, executed by the Ministry of Health, Welfare and Sports of the Netherlands. A written informed consent was obtained from all participants.
Carotid MRI Scanning and Analysis of Plaque Characteristics
Imaging was performed with a 1.5-Tesla scanner (GE Healthcare, Milwaukee, WI) with a bilateral phased-array surface coil (Machnet, Eelde, The Netherlands). A standard scanning protocol was used with a total scanning time of ≈30 minutes. The carotid MRI protocol, reading, and reproducibility are described elsewhere. 16 We evaluated both carotid arteries over a range of 15 mm caudally to 30 mm cranially of the bifurcation. We assessed plaque characteristics in all plaques with a maximum thickness of ≥2.0 mm on MRI. On the proton density weighted fast spin echo images, maximum carotid wall thickness was measured, and degree of luminal stenosis was calculated using the North American Symptomatic Carotid Endarterectomy Trial criteria. 17 Plaques were reviewed for the presence of 3 different plaque components; IPH, lipid core, and calcification. In short, we defined IPH as the presence of a hyperintense focus within the plaque on the 3-dimensional T1-weighted gradient radio echo sequence. 16 Calcification was defined as a hypointense region in the plaque on all sequences. Finally, the presence of lipid core was defined as a hypointense region in the plaque on proton density weighted fast spin echo or proton density weighted echo planar image and T2-weighted echo planar image, or a region of relative signal intensity drop in the T2-weighted echo planar images compared with the proton density weighted echo planar image. Multiple components were permissible in one plaque. 16 
History of Stroke or CHD
A history of ischemic stroke or CHD was based on either a history of event self-reported at study entry, verified by clinical data from the medical records, or the occurrence of an event during study follow-up but before the time of carotid MRI scanning. The follow-up system involved linkage of the study to files from general practitioners in the study area and subsequent collection of information from letters of medical specialists, brain imaging, and discharge reports in case of hospitalization. For the diagnosis of stroke and cardiac events, 2 research physicians independently coded all reported events according to the International Classification of Diseases, 10th Revision. 18 In case of disagreement, a decision was made by a neurologist or cardiologist. Stroke was defined as a history of ischemic or unspecified stroke but not hemorrhagic stroke (International Classification of Diseases, 10th Revision codes I61, I63, and I64). 19 To define CHD, we used a combined outcome of nonfatal myocardial infarction and myocardial revascularization (ie, percutaneous coronary intervention and coronary artery bypass grafting, International Classification of Diseases, 10th Revision codes I21, I24, and I25). 20 Information on incidence of stroke and CHD was completed until January 1, 2012.
Assessment of Covariates
Information on cardiovascular risk factors was obtained from the visit to the research center, which took place before the MRI scanning. Smoking status was classified as ever or never. Serum total cholesterol and high-density lipoprotein-cholesterol values were measured using standard laboratory techniques. On the basis of weight and height, the body mass index was calculated. Diabetes mellitus was defined as a fasting blood glucose >7.0 mmol/L, nonfasting glucose >11.0 mmol/L, or use of antidiabetic medication. Blood pressure was measured using a random-zero sphygmomanometer at the study center visit. Hypertension was defined as a blood pressure >140/90 mm Hg or the use of antihypertensive medication. Medication dispensing data were obtained from the fully computerized pharmacies in the Ommoord suburb. Information on all filled prescriptions of antihypertensive drugs on date of carotid MRI scans was available.
Statistical Analysis
We compared the baseline characteristics between men and women using age-adjusted linear regression for continuous variables and logistic regression for dichotomous variables. We also examined the mean wall thickness and degree of stenosis in persons with and without IPH, lipid core, and calcification (Table I in the online-only Data Supplement). 16 To investigate the relation of the different plaque characteristics (IPH, lipid, calcification, stenosis [per 10%], and carotid wall thickness) with the history of ischemic stroke and CHD, we used binomial logistic regression. Next, we analyzed these relations in the whole sample and for men and women separately. In the first model, analyses were adjusted for age, sex (in the overall model only), and carotid wall thickness (only for the analyses with IPH, lipid, and calcification as determinant). In the second models, we additionally adjusted the associations for cardiovascular risk factors (smoking, total cholesterol, high-density lipoprotein-cholesterol, body mass index, diabetes mellitus, and hypertension).
We also evaluated effect modification by sex. Finally, we performed additional analyses in which all plaque characteristics were further adjusted for the other plaque components (Tables I and II in the online-only Data Supplement).
All analyses were carried out using SPSS Statistical Package version 20.0 (Chicago, IL). Missing values in the covariates were imputed using the Expectation Maximization method. . When we tested for effect modification by sex, we only found the interaction term with IPH to be significant (P=0.03). Lipid, calcification, and carotid wall thickness were not associated with stroke in the fully adjusted model. Table 3 shows overall and sex-specific associations between plaque characteristics and history of CHD, adjusted for age, carotid wall thickness (model 1), and for cardiovascular risk factors (model 2). In the overall analysis, only carotid stenosis was significantly associated with CHD after adjustment for cardiovascular risk factors (OR per 10% increase 1.14 [95% CI, 1.06-1.22]). Stratifying for sex did not materially change this association in both men and women. Also, carotid wall thickness was significantly associated with CHD in men (OR, 1.20 [95% CI, 1.03-1.39]) but not in women (OR, 1.21 [95% CI, 0.88-1.65]). For carotid stenosis and wall thickness, no effect modification by sex was observed (data not shown). None of the various plaque components was associated with the history of CHD, also after stratification for sex. All analyses for the association between plaque characteristics and stroke and CHD were repeated with additional adjustment for the remaining plaque components, but this did not alter the results (Tables II and III in the online-only Data Supplement).
Results
Discussion
In this population-based study, we found carotid atherosclerotic plaque characteristics to be differentially related to history of ischemic stroke and CHD. Whereas the extent of atherosclerosis, expressed as plaque thickness or stenosis, was associated both with the history of ischemic stroke and CHD, plaque composition, and specifically IPH, seemed to be associated with the history of stroke only. These associations were primarily present in men and less prominent in women.
The relation between carotid IMT as measured with B-mode ultrasound and cardiovascular disease has been well established and IMT serves as a marker of generalized atherosclerosis. [9] [10] [11] To this extent, IMT has been increasingly used for risk stratification models and contributes greatly to the prediction of CHD. 10, 22 To our knowledge, no studies have mainly focused on the relation between carotid plaque composition as detected with MRI and CHD. Most imaging studies used ultrasound measurements, because these measurements are relatively simple and noninvasive, but the resolution is of limited value for characterization of plaque composition. 23 By using MRI, we found that carotid wall thickness and stenosis are more associated with a history of CHD than any of the specific carotid plaque components.
We found a prominent association of stenosis and IPH with history of stroke, which is in line with several clinical studies that investigated carotid plaque composition and neurological ischemic events. 2, 3, [24] [25] [26] In a meta-analysis among 394 asymptomatic subjects, it was found that especially IPH was related to a substantially increased risk of stroke (hazard ratio, 3.5). 2 However, because atherosclerosis is a chronic inflammatory condition with various local and systemic manifestations, 27 researchers have raised the hypothesis that plaque instability may also be a systemic condition, influenced by systemic risk factors. 28, 29 For this reason, the term vulnerable patient was introduced, indicating that changes found in 1 vessel bed may be predictive of risk of events in another vessel bed. 6, 12 Whereas several reports previously suggested 30-32 we did not find any significant association between any of the carotid plaque components and history of CHD. Although we used previous clinical history with no clear information on how long exactly the CHD event had occurred before the carotid artery was imaged, carotid plaque composition seemed to be less important for CHD than for ischemic stroke. A possible explanation for the discrepancy with previous literature is that some of these studies used carotid tissue specimens derived after carotid endarterectomy or autopsy, in which it is difficult to distinguish between IPH and intraluminal thrombi after the tissue preparation. Other explanations may be related with the fact that others used a composite end point of cerebral and cardiovascular disease, or did not stratify for sex. This may have resulted in a dilution of the association between IPH with stroke and an overestimation of the association with CHD. Furthermore, a precise mechanism describing how atherosclerosis in one vessel bed can lead to clinical events other than in their corresponding territory remains unclear. Some studies suggested that the presence of IPH observed in one vessel bed might reflect a systemic susceptibility for vulnerable plaques in other vessel beds. 33, 34 Because atherosclerotic plaques with IPH are generally thicker than plaques without IPH, 16 individuals with IPH could possibly have complications of the extent of atherosclerosis rather than the vulnerability of the plaque.
With respect to clinical events, we found that carotid atherosclerotic plaque characteristics differed between men and women. These differences could, in part, be explained by the smaller number of CHD events in women, leading to a lack in statistical power, as the estimates for the association between plaque thickness and stenosis and CHD were similar in women as in men. Alternatively, the larger OR of the association between IPH and history of stroke that we observed in men as opposed to women is in line with the male predominance of IPH as observed in several other studies. 16, 32, 35, 36 In a recent study of symptomatic patients who underwent carotid endarterectomy, IPH seemed to be associated with an increased risk of stroke and cardiovascular events in men, but not in women.
32 A possible explanation may relate to more efficient repair, as stable, more fibrous less inflammatory, plaques were found in women, especially asymptomatic women, compared with men in histology studies. 36 It was also suggested that although women may have similar amount of atherosclerosis, they may differ in clinical presentation of CHD or stroke because of estrogen-or genetic-related reasons.
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Several strengths and limitations of our study need to be addressed. The advantages of this study are the populationbased design and the large sample size. Furthermore, we focused on history of stroke and CHD separately instead of restricting the study to 1 end organ or using composite end 
